Insight Molecular Diagnostics Inc. Cash and Restricted Cash
Insight Molecular Diagnostics Inc. (IMDX) had Cash and Restricted Cash of $19.07 million as of 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2023-08-10
- 2023-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $19.07M.
- 2023-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $13.50M.
- 2022-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $23.20M.
- 2022-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $33.75M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2023-06-30 | $19.07M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $13.50M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $23.20M 10-Q · filed 2023-08-10 |
| 2022-09-30 | $33.75M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $46.54M 10-Q · filed 2022-08-12 |
| 2021-12-31 | $37.30M 10-K · filed 2023-04-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |